Because of the increased mad1 mRNA and c-Myc expression in psoriasis and wound epidermis (Miyoshi et al., 2011; Nakajima et al., 2019; Sano et al., 2005; Bedini et al., 2007; Li et al., 2007; Zhang et al., 2008), targeting either mad1 mRNA and c-Myc can be beneficial for psoriasis. Here, MYC is linked to psoriasis.